Clinical Trial Update: Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics and pharmacodynamics study of GW642444 in pediatric asthma patients with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW642444 (GW642444)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-19